Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 4Other hematologic neoplasm 4Lymphoid 4Genitourinary 3Tumor-Agnostic 2Sarcoma 1Plasma cell 1Myeloid 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 3Neoplasm Metastasis 1

Interventions

Prednisone 122Docetaxel 118enzalutamide 101pembrolizumab 96Sunitinib 86Leuprolide 84Abiraterone Acetate 83Nivolumab 78Gemcitabine 76bicalutamide 54Radiotherapy 54Goserelin 54Bevacizumab 54Cisplatin 52Magnetic Resonance Spectroscopy 49Everolimus 49acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 46Sorafenib 40Carboplatin 40Paclitaxel 37Radiosurgery 36atezolizumab 35abiraterone 33pazopanib 32cabozantinib 32Ipilimumab 32Axitinib 30Cyclophosphamide 29Androgen Antagonists 29Radiation 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Itraconazole × Genitourinary × Clear all
NCT01787331 2020-02-05

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

University of California, San Francisco

Phase 2 Completed
21 enrolled 16 charts
Genitourinary

Prostatic Neoplasms

NCT00887458 2017-10-16

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Johns Hopkins University

Phase 2 Completed
46 enrolled 8 charts
Genitourinary

Prostatic Neoplasms

NCT01450683 2017-04-11

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Stanford University

Phase 2 Terminated
4 enrolled 4 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡